SailPoint outlines FY2029 targets including at least $2.1B ARR amid agentic AI push (NASDAQ:SAIL)September 9, 2026
Share Facebook Twitter LinkedIn Pinterest Email Relay Therapeutics prices $275M public offering of common stock at $12/share
SailPoint outlines FY2029 targets including at least $2.1B ARR amid agentic AI push (NASDAQ:SAIL)September 9, 2026
Chime Financial initiated with Buy at Loop Capital, price target set at $45 (CHYM:NASDAQ)September 9, 2026
By Press Room
By Press Room
By Press Room
